Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001420506-25-000689
Filing Date
2025-03-21
Accepted
2025-03-21 19:15:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9735
2 AGREEMENT OF THE REPORTING PERSONS (500) ex99-1.htm EX-99 3322
3 SUBSIDIARY INFORMATION (500) ex99-2.htm EX-99 987
  Complete submission text file 0001420506-25-000689.txt   15781
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Subject) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-87872 | Film No.: 25761940
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1345 AVENUE OF THE AMERICAS 47TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 47TH FLOOR NEW YORK NY 10105 917-769-2999
Bleichroeder LP (Filed by) CIK: 0001781002 (see all company filings)

EIN.: 842006600 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A